Cargando…
Systematic review of fondaparinux for heparin‐induced thrombocytopenia: When there are no randomized controlled trials
BACKGROUND: Fondaparinux is commonly used for treatment of heparin‐induced thrombocytopenia (HIT) despite lack of approval for this indication. High quality randomized controlled trials of this agent are unlikely to be forthcoming. OBJECTIVES: The objective of this systematic review is to update the...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178656/ https://www.ncbi.nlm.nih.gov/pubmed/30349886 http://dx.doi.org/10.1002/rth2.12145 |